Azora Therapeutics Insider Trades
NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $106.33K
- Sales
- 0 · $0
- Shares bought / sold
- 39.99K / 0
- Net activity
- Net buying $106,329
Azora Therapeutics insider activity
Over the last 12 months, Azora Therapeutics insiders reported 19 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $106,329 and sold $0 worth of stock, for net insider buying of $106,329. The most recent filing shows Davidson Matt (President and CEO) reporting a transaction in 524,954 shares on Nov 2, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AZR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AZR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 2, 2026 | Saiki JulieChief Strategy Officer | Conversion | 626,252 | — | Form 4 |
| Nov 2, 2026 | Davidson MattPresident and CEO | Conversion | 101,298 | — | Form 4 |
| Nov 2, 2026 | Davidson MattPresident and CEO | Conversion | 524,954 | — | Form 4 |
| Oct 28, 2026 | Davidson MattPresident and CEO | Award | 232,417 | — | Form 4 |
| Jul 16, 2026 | Coastlands Capital LP10% Owner | Buy | 1,233 | $3.39K | Form 4 |
| Jul 14, 2026 | Coastlands Capital LP10% Owner | Buy | 2,000 | $5.30K | Form 4 |
| Jul 10, 2026 | Coastlands Capital LP10% Owner | Buy | 1,700 | $4.59K | Form 4 |
| Jul 9, 2026 | Coastlands Capital LP10% Owner | Buy | 10,053 | $28.05K | Form 4 |
| Jun 29, 2026 | Coastlands Capital LP10% Owner | Buy | 25,000 | $65.00K | Form 4 |
| Jun 12, 2026 | Davidson MattChief Development Officer | Award | 232,417 | — | Form 4 |
| Jun 11, 2026 | Davidson MattChief Development Officer | Award | 101 | — | Form 4 |
| Jun 11, 2026 | Davidson MattChief Development Officer | Award | 1,822 | — | Form 4 |
| Jun 11, 2026 | Davidson MattChief Development Officer | Award | 3,427 | — | Form 4 |
| Jun 11, 2026 | Davidson MattChief Development Officer | Award | 61,647 | — | Form 4 |
| Apr 7, 2026 | Shah VinayChief Financial Officer | Award | 17,325 | — | Form 4 |
| Apr 7, 2026 | Schuyler KevinDirector | Award | 9,185 | — | Form 4 |
| Apr 7, 2026 | Claiborne Cary JChief Executive Officer | Award | 37,985 | — | Form 4 |
| Apr 7, 2026 | Gilliland Robertson H.Director | Award | 9,185 | — | Form 4 |
| Apr 7, 2026 | Goodman TonyChief Operating Officer | Award | 26,510 | — | Form 4 |
| Sep 29, 2023 | Schuyler KevinDirector | Buy | 700 | $1.92K | Form 4 |
| May 23, 2023 | Claiborne Cary JChief Executive Officer | Award | 420,000 | — | Form 4 |
| May 23, 2023 | Stilley William B. IIIDirector | Award | 240,800 | — | Form 4 |
| May 23, 2023 | Truluck JosephChief Financial Officer | Award | 157,500 | — | Form 4 |
| Dec 30, 2022 | Stilley William B. IIIDirector | Disposition | 166,667 | — | Form 4 |
| Sep 20, 2022 | Claiborne Cary JChief Executive Officer | Award | 75,000 | $31.52K | Form 4 |
| Sep 19, 2022 | Claiborne Cary JChief Executive Officer | Award | 25,000 | $10.73K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4